The results showed a trend toward better survival with the platinum doublet, with the median OS being 11.1 months in comparison to 6.3 months with capecitabine alone.
1
—
—
The results showed a trend toward better survival with the platinum doublet, with the median OS being 11.1 months in comparison to 6.3 months with capecitabine alone.